Cargando…

Expert perspectives on hereditary angioedema: Key areas for advancements in care across the patient journey

BACKGROUND: Published literature documents the substantial burden of hereditary angioedema (HAE) with C1 inhibitor deficiency on the quality of life and work productivity of patients. However, despite advances in the field and the availability of guidelines to advise health care providers (HCP) on t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banerji, Aleena, Baş, Murat, Bernstein, Jonathan A., Boccon-Gibod, Isabelle, Bova, Maria, Dempster, John, Grumach, Anete Sevciovic, Magerl, Markus, Poarch, Kimberly, Ferreira, Manuel Branco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OceanSide Publications, Inc. 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244276/ https://www.ncbi.nlm.nih.gov/pubmed/27661998 http://dx.doi.org/10.2500/ar.2016.7.0165

Ejemplares similares

Hereditary angioedema: how to approach it at the emergency department?
por: Serpa, Faradiba Sarquis, et al.
Publicado: (2021)

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series
por: Maurer, Marcus, et al.
Publicado: (2022)

Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant
por: Bouillet, Laurence, et al.
Publicado: (2017)

Hereditary Angioedema-Associated Acute Pancreatitis in C1-Inhibitor Deficient and Normal C1-Inhibitor Patients: Case Reports and Literature Review
por: Veronez, Camila Lopes, et al.
Publicado: (2019)

Optimal Management of Hereditary Angioedema: Shared Decision-Making
por: Banerji, Aleena, et al.
Publicado: (2021)

Current challenges and future opportunities in patient‐focused management of hereditary angioedema: A narrative review
por: Grumach, Anete S., et al.
Publicado: (2023)

The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency
por: Zanichelli, Andrea, et al.
Publicado: (2021)

WAO Guideline for the Management of Hereditary Angioedema
por: Craig, Timothy, et al.
Publicado: (2012)

Consider Hereditary Angioedema in the Differential Diagnosis for Unexplained Recurring Abdominal Pain
por: Staller, Kyle, et al.
Publicado: (2022)

Genetic Variation of Kallikrein-Kinin System and Related Genes in Patients With Hereditary Angioedema
por: Veronez, Camila Lopes, et al.
Publicado: (2019)

Profile of serious angioedema requiring an urgent advice from a national reference call center
por: Simon, Nicolas, et al.
Publicado: (2022)

Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study
por: Campos, Regis Albuquerque, et al.
Publicado: (2014)

Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study
por: Banerji, Aleena, et al.
Publicado: (2021)

A Germany-wide survey study on the patient journey of patients with hereditary angioedema
por: Magerl, Markus, et al.
Publicado: (2020)

Brazilian guidelines for the diagnosis and treatment of hereditary angioedema
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2011)

Hereditary angioedema: quality of life in Brazilian patients
por: Gomide, Maria Abadia Consuelo M S, et al.
Publicado: (2013)

Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
por: Zanichelli, Andrea, et al.
Publicado: (2018)

Correction to: A Germany-wide survey study on the patient journey of patients with hereditary angioedema
por: Magerl, Markus, et al.
Publicado: (2021)

Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks
por: Riedl, Marc A., et al.
Publicado: (2020)

Are pediatricians familiar with hereditary angioedema?
por: Chong-Neto, Herberto José, et al.
Publicado: (2023)

The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
por: Maurer, Marcus, et al.
Publicado: (2022)

Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants
por: Marceau, François, et al.
Publicado: (2020)

Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study
por: Lumry, William R., et al.
Publicado: (2020)

Inborn Errors of Immunity: how to diagnose them?
por: Grumach, Anete Sevciovic, et al.
Publicado: (2021)

Hereditary angioedema without deficiency of C1 inhibitor: response to therapy
por: Pimenta, Fabiane Milena Castro Araújo, et al.
Publicado: (2015)

Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor
por: Gabriel, Natalia, et al.
Publicado: (2022)

An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension
por: Riedl, Marc A., et al.
Publicado: (2017)

Angioedema Without Wheals: Challenges in Laboratorial Diagnosis
por: Grumach, Anete S., et al.
Publicado: (2021)

Dedicated call center (SOS-HAE) for hereditary angioedema attacks: study protocol for a randomised controlled trial
por: Javaud, Nicolas, et al.
Publicado: (2016)

COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency
por: Grumach, Anete S., et al.
Publicado: (2021)

The International/Canadian Hereditary Angioedema Guideline
por: Betschel, Stephen, et al.
Publicado: (2019)

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency
por: Farkas, H., et al.
Publicado: (2016)

The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries
por: Caballero, T., et al.
Publicado: (2017)

Hereditary angioedema with C1 inhibitor deficiency: experience of a new reference center
por: Palma, Sandra Mitie Ueda, et al.
Publicado: (2015)

Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study
por: Johnston, Douglas T., et al.
Publicado: (2021)

Roles of Immune Cells in Hereditary Angioedema
por: Ferrara, Anne Lise, et al.
Publicado: (2021)

Correction to: The International/Canadian Hereditary Angioedema Guideline
por: Betschel, Stephen, et al.
Publicado: (2020)

Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States
por: Riedl, Marc A, et al.
Publicado: (2018)

Determining biomarkers for evaluation and diagnosis of hereditary angioedema
por: Singh, Umesh, et al.
Publicado: (2022)

Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey
por: Bygum, Anette, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n57n5rancu1pgiftqursua4cgv